JP Morgan Chase’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.28M | Buy |
96,882
+17,016
| +21% | +$441K | ﹤0.01% | 4004 |
|
|
2025
Q4 | $2.03M | Buy |
79,866
+4,536
| +6% | +$101K | ﹤0.01% | 4060 |
|
|
2025
Q3 | $1.21M | Sell |
75,330
-402,933
| -84% | -$6.52M | ﹤0.01% | 4445 |
|
|
2025
Q2 | $7.65M | Sell |
478,263
-174,456
| -27% | -$2.64M | ﹤0.01% | 2778 |
|
|
2025
Q1 | $11.2M | Sell |
652,719
-500,619
| -43% | -$10.5M | ﹤0.01% | 2439 |
|
|
2024
Q4 | $28.6M | Buy |
1,153,338
+925,081
| +405% | +$26.2M | ﹤0.01% | 1709 |
|
|
2024
Q3 | $6.51M | Sell |
228,257
-28,586
| -11% | -$843K | ﹤0.01% | 3008 |
|
|
2024
Q2 | $6.78M | Buy |
256,843
+11,810
| +5% | +$336K | ﹤0.01% | 2797 |
|
|
2024
Q1 | $7.92M | Sell |
245,033
-225,957
| -48% | -$8.24M | ﹤0.01% | 2698 |
|
|
2023
Q4 | $19.8M | Buy |
470,990
+42,482
| +10% | +$1.56M | ﹤0.01% | 1866 |
|
|
2023
Q3 | $16.5M | Sell |
428,508
-14,001
| -3% | -$316K | ﹤0.01% | 1843 |
|
|
2023
Q2 | $8.39M | Buy |
442,509
+380,517
| +614% | +$7.1M | ﹤0.01% | 2439 |
|
|
2023
Q1 | $961K | Buy |
61,992
+11,578
| +23% | +$201K | ﹤0.01% | 4070 |
|
|
2022
Q4 | $895K | Sell |
50,414
-112,794
| -69% | -$1.42M | ﹤0.01% | 4126 |
|
|
2022
Q3 | $911K | Sell |
163,208
-489,973
| -75% | -$2.4M | ﹤0.01% | 4070 |
|
|
2022
Q2 | $2.55M | Buy |
653,181
+191,599
| +42% | +$828K | ﹤0.01% | 3339 |
|
|
2022
Q1 | $2.54M | Buy |
461,582
+310,520
| +206% | +$1.93M | ﹤0.01% | 3567 |
|
|
2021
Q4 | $1.29M | Sell |
151,062
-207,731
| -58% | -$1.71M | ﹤0.01% | 4203 |
|
|
2021
Q3 | $3.12M | Buy |
358,793
+328,156
| +1,071% | +$2.96M | ﹤0.01% | 3422 |
|
|
2021
Q2 | $324K | Buy |
30,637
+5,378
| +21% | +$75.1K | ﹤0.01% | 4965 |
|
|
2021
Q1 | $406K | Buy |
25,259
+4,384
| +21% | +$116K | ﹤0.01% | 4809 |
|
|
2020
Q4 | $964K | Buy |
20,875
+3,656
| +21% | +$169K | ﹤0.01% | 3993 |
|
|
2020
Q3 | $627K | Buy |
17,219
+1,142
| +7% | +$34.3K | ﹤0.01% | 3879 |
|
|
2020
Q2 | $392K | Buy |
16,077
+13,169
| +453% | +$282K | ﹤0.01% | 3954 |
|
|
2020
Q1 | $45K | Buy |
+2,908
| New | +$43.7K | ﹤0.01% | 4755 |
|
Other funds holding IMVT
DTC
BBA
TCM
VPM
VCM
